Phocas Financial Corp
MIRM icon

Phocas Financial Corp’s Mirum Pharmaceuticals MIRM Stock Holding History

Phocas Financial Corp’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-14,637
Closed -$1.71M – 88
2026
Q2 		$1.71M Buy
+14,637
New +$1.47M 0.24% 120
2025
Q3 		– Sell
-35,561
Closed -$1.81M – 154
2025
Q2 		$1.81M Buy
35,561
+5
+0% +$223 0.26% 105
2025
Q1 		$1.6M Sell
35,556
-2,029
-5% -$95.6K 0.25% 109
2024
Q4 		$1.55M Buy
+37,585
New +$1.57M 0.21% 118

Other funds holding MIRM

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Eventide Asset Management
Eventide Asset Management Boston, Massachusetts $7.14B AUM 65.02% 1-Year Est. Return

Phocas Financial Corp's MIRM Position: Q3 2026 in Review

Phocas Financial Corp sold out of Mirum Pharmaceuticals (MIRM) in Q3 2026, closing a stake of 14,637 shares — an estimated $1.71M sold.

Phocas Financial Corp first reported a position in MIRM in Q4 2024 and held it in 4 quarters. The position peaked at $1.81M in Q2 2025. 231 funds tracked by Wall St. Rank hold MIRM as of Q3 2026.

  • Phocas Financial Corp reported no remaining Mirum Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Phocas Financial Corp sold 14,637 Mirum Pharmaceuticals shares in Q3 2026, an estimated $1.71M.
  • Phocas Financial Corp first reported a position in Mirum Pharmaceuticals in Q4 2024 and held it in 4 quarters.
  • Phocas Financial Corp's Mirum Pharmaceuticals position peaked at $1.81M in Q2 2025.
  • 231 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2026.

Based on Phocas Financial Corp's 13F filing for Q3 2026.